Pharmacists in Vaud have expressed frustration and disappointment with the reimbursement policies set by the Swiss Federal Office of Public Health (FOPH), particularly regarding the Pfizer Covid vaccine.
They argue that these policies impose an economic strain on their operations, especially in rural areas where pharmacies are vital to community health.
The requirement to purchase vaccines in bulk while selling them individually complicates inventory management and incurs additional handling and storage costs that are not adequately compensated.
This has become a financial burden for pharmacies, especially considering the high costs associated with other medications.
The pharmacists argue that the FOPH's decisions disproportionately affect them and do not consider their role as critical healthcare providers.
They emphasize that administering vaccines involves more than just the act of injection and requires careful preparation, expertise, and ongoing patient support.
The pharmacists are calling for a reevaluation of reimbursement rates and a dialogue that recognizes the comprehensive nature of their services.
They want the reimbursement structure to reflect the integral role they play in public health.
The pharmacists' letter highlights the need for policies that support the essential services provided by pharmacies and the ongoing dialogue between pharmacists and health authorities to shape a more equitable and sustainable healthcare system.